Targeting the 90kDa heat shock protein improves photodynamic therapy
- 28 March 2010
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 289 (2), 188-194
- https://doi.org/10.1016/j.canlet.2009.08.015
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Heat Shock Protein 90 as a Drug Target: Some Like It HotClinical Cancer Research, 2008
- A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate CancerClinical Cancer Research, 2008
- Drugging the Cancer Chaperone HSP90Annals of the New York Academy of Sciences, 2007
- Apoptosis and Autophagy After Mitochondrial or Endoplasmic Reticulum Photodamage†Photochemistry and Photobiology, 2007
- Multiple Components of Photodynamic Therapy Can Phosphorylate Akt†Photochemistry and Photobiology, 2007
- Antileukemic Activity of Shepherdin and Molecular Diversity of Hsp90 InhibitorsJNCI Journal of the National Cancer Institute, 2006
- Identification of new biomarkers for clinical trials of Hsp90 inhibitorsMolecular Cancer Therapeutics, 2006
- Celecoxib and NS-398 Enhance Photodynamic Therapy by Increasing In vitro Apoptosis and Decreasing In vivo Inflammatory and Angiogenic FactorsCancer Research, 2005
- Inhibitory Effect of Heat Shock Protein 70 on Apoptosis Induced by Photodynamic Therapy In Vitro¶Photochemistry and Photobiology, 2004
- Photodynamic therapy for cancerNature Reviews Cancer, 2003